Financial Ratios Merchavia Holdings and Investments Ltd

Equities

MRHL

IL0002570146

Biotechnology & Medical Research

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 10:24:52 2026-05-20 am EDT			5-day change	1st Jan Change
175.30 ^ILa	+0.46%		+3.48%	-18.65%

Mar. 31	Merchavia Holdings and Investments Ltd Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Dec. 10	E.F.A. Engineering For All Ltd announced that it expects to receive $2 million in funding from Merchavia Holdings and Investments Ltd	CI

9d03309a712b7d6dbe552df60db3b.3McWXoGj9XfHQ7bHmxSACQx0VoUpIUA6GbcgbUlFH3U.7YRgG-rrmCGVGoeV7yLxSGI4OdpBazlNbuVlBQYGUUO9okAq6ZLCBa96_w

Published financial data: MERCHAVIA HOLDINGS AND INVESTMENTS LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Gain (Loss) on Sale of Investment, Total (Rev)	10.06M	4.02M	1.72M	71K	-
Interest And Invest. Income (Rev)	-	34K	125K	48K	44K
Other Revenues, Total	550K	110K	-	-	-
Total Revenues	10.61M	4.16M	1.85M	119K	44K
Gross Profit	10.61M	4.16M	1.85M	119K	44K
Selling General & Admin Expenses, Total	3.4M	2.72M	2.39M	2.83M	1.92M
Other Operating Expenses	59K	-17K	-317K	-324K	-329K
Other Operating Expenses, Total	3.46M	2.7M	2.07M	2.51M	1.59M
Operating Income	7.15M	1.46M	-221K	-2.39M	-1.54M
Interest Expense, Total	-	-	-	-	-12K
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-	-	-	-	-12K
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-26K	13K	18K	1K	25K
Other Non Operating Income (Expenses)	-	-	-2K	1.5M	15K
EBT, Excl. Unusual Items	7.12M	1.47M	-205K	-888K	-1.51M
Gain (Loss) On Sale Of Investments	-1.27M	-5.08M	-16.03M	-6.08M	-8.65M
EBT, Incl. Unusual Items	5.85M	-3.61M	-16.23M	-6.97M	-10.16M
Earnings From Continuing Operations	5.85M	-3.61M	-16.23M	-6.97M	-10.16M
Net Income to Company	5.85M	-3.61M	-16.23M	-6.97M	-10.16M
Net Income - (IS)	5.85M	-3.61M	-16.23M	-6.97M	-10.16M
Net Income to Common Incl Extra Items	5.85M	-3.61M	-16.23M	-6.97M	-10.16M
Net Income to Common Excl. Extra Items	5.85M	-3.61M	-16.23M	-6.97M	-10.16M
Per Share Items
Net EPS - Basic	0.36	-0.21	-0.96	-0.41	-0.5
Basic EPS - Continuing Operations	0.36	-0.21	-0.96	-0.41	-0.5
Basic Weighted Average Shares Outstanding	16.27M	17.32M	16.97M	17.04M	20.12M
Net EPS - Diluted	0.35	-0.21	-0.96	-0.41	-0.5
Diluted EPS - Continuing Operations	0.35	-0.21	-0.96	-0.41	-0.5
Diluted Weighted Average Shares Outstanding	16.27M	17.32M	16.97M	17.04M	20.12M
Normalized Basic EPS	0.27	0.05	-0.01	-0.03	-0.05
Normalized Diluted EPS	0.27	0.05	-0.01	-0.03	-0.05
Supplemental Items
EBITDA	7.16M	1.47M	-209K	-2.38M	-1.54M
EBITA	7.15M	1.46M	-221K	-2.39M	-1.54M
EBIT	7.15M	1.46M	-221K	-2.39M	-1.54M
Total Revenues (As Reported)	10.61M	4.26M	2.18M	1.94M	415K
Normalized Net Income	4.45M	921K	-128K	-555K	-946K
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	3.4M	2.72M	2.39M	2.83M	1.92M
Stock-Based Comp., G&A Exp. (Total)	1.21M	660K	216K	812K	1K
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	1.21M	660K	216K	812K	1K

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	7.43M	4.08M	2.2M	1.38M	352K
Short Term Investments	-	172K	-	-	-
Total Cash And Short Term Investments	7.43M	4.25M	2.2M	1.38M	352K
Other Receivables	408K	331K	245K	172K	316K
Notes Receivable	-	-	-	-	-
Total Receivables	408K	331K	245K	172K	316K
Prepaid Expenses	4K	13K	14K	14K	16K
Other Current Assets, Total	6K	-	-	16K	50K
Total Current Assets	7.85M	4.59M	2.46M	1.58M	734K
Net Property Plant And Equipment	12K	13K	16K	8K	1K
Long-term Investments	40.08M	40.62M	27.16M	21.3M	15.1M
Loans Receivable Long-Term	554K	533K	499K	2M	2M
Other Long-Term Assets, Total	225K	-	-	-	-
Total Assets	48.72M	45.76M	30.12M	24.89M	17.83M
Liabilities
Accounts Payable, Total	378K	326K	438K	412K	530K
Accrued Expenses, Total	348K	372K	661K	913K	1.13M
Short-term Borrowings	-	-	-	-	751K
Current Portion of Long-Term Debt	-	-	-	-	-
Unearned Revenue Current, Total	-	-	80K	120K	-
Other Current Liabilities	92K	144K	48K	49K	49K
Total Current Liabilities	818K	842K	1.23M	1.49M	2.46M
Other Non Current Liabilities	45K	-	-	-	-
Total Liabilities	863K	842K	1.23M	1.49M	2.46M
Common Stock, Total	12.88M	12.88M	12.88M	-	-
Additional Paid In Capital	35.18M	35.84M	36.05M	50.41M	52.54M
Retained Earnings	1.1M	-2.5M	-18.74M	-25.71M	-35.87M
Treasury Stock	-1.3M	-1.3M	-1.3M	-1.3M	-1.3M
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	47.86M	44.91M	28.9M	23.4M	15.38M
Total Equity	47.86M	44.91M	28.9M	23.4M	15.38M
Total Liabilities And Equity	48.72M	45.76M	30.12M	24.89M	17.83M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	16.43M	16.8M	16.8M	17.8M	21M
ECS Total Common Shares Outstanding	16.43M	16.8M	16.8M	17.8M	21M
Book Value / Share	2.91	2.67	1.72	1.31	0.73
Tangible Book Value	47.86M	44.91M	28.9M	23.4M	15.38M
Tangible Book Value Per Share	2.91	2.67	1.72	1.31	0.73
Total Debt	0	0	0	0	751K
Net Debt	-7.43M	-4.25M	-2.2M	-1.38M	399K
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Full Time Employees	1	1	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	5.85M	-3.61M	-16.23M	-6.97M	-10.16M
Depreciation & Amortization - CF	8K	8K	12K	8K	7K
Depreciation & Amortization, Total	8K	8K	12K	8K	7K
(Gain) Loss on Sale of Investments - (CF)	-8.98M	1.06M	14.3M	5.95M	8.65M
Net (Increase) Decrease in Loans Originated / Sold - Operating	-	-	-	-	-15K
Provision for Credit Losses	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	1.21M	660K	216K	812K	1K
Other Operating Activities, Total	-388K	-110K	-58K	-1.56M	-
Change In Accounts Receivable	-5K	-98K	-140K	73K	-146K
Change In Accounts Payable	-302K	24K	327K	227K	211K
Cash from Operations	-2.61M	-2.06M	-1.57M	-1.46M	-1.46M
Capital Expenditure	-	-9K	-15K	-	-
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-3.26M	-1.77M	-550K	-	-2.44M
Net (Increase) Decrease in Loans Originated / Sold - Investing	96K	21K	34K	-	-
Other Investing Activities, Total	599K	507K	225K	-16K	-34K
Cash from Investing	-2.57M	-1.25M	-306K	-16K	-2.48M
Short Term Debt Issued, Total	-	-	-	-	770K
Total Debt Issued	-	-	-	-	770K
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-45K	-45K	-22K	-	-
Total Debt Repaid	-45K	-45K	-22K	-	-
Issuance of Common Stock	3.59M	-	-	662K	2.13M
Cash from Financing	3.55M	-45K	-22K	662K	2.9M
Foreign Exchange Rate Adjustments	-	-	18K	-	-
Net Change in Cash	-1.63M	-3.35M	-1.88M	-814K	-1.03M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Levered Free Cash Flow	5.78M	1.67M	545K	-348K	-932K
Unlevered Free Cash Flow	5.78M	1.67M	545K	-348K	-925K
Change In Net Working Capital	-93K	-98K	-470K	-324K	-31K
Net Debt Issued / Repaid	-45K	-45K	-22K	-	770K

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.25	1.93	-0.36	-5.42	-4.51
Return on Total Capital	10.5	1.97	-0.37	-5.71	-4.88
Return On Equity %	13.76	-7.78	-43.98	-26.67	-52.4
Return on Common Equity	13.76	-7.78	-43.98	-26.67	-52.4
Margin Analysis
Gross Profit Margin %	100	100	100	100	100
SG&A Margin	32.08	65.3	129.11	2.38K	4.35K
EBITDA Margin %	67.44	35.3	-11.31	-2K	-3.49K
EBITA Margin %	67.37	35.11	-11.96	-2.01K	-3.5K
EBIT Margin %	67.37	35.11	-11.96	-2.01K	-3.5K
Income From Continuing Operations Margin %	55.16	-86.69	-878.3	-5.86K	-23.09K
Net Income Margin %	55.16	-86.69	-878.3	-5.86K	-23.09K
Net Avail. For Common Margin %	55.16	-86.69	-878.3	-5.86K	-23.09K
Normalized Net Income Margin	41.95	22.14	-6.93	-466.39	-2.15K
Levered Free Cash Flow Margin	54.45	40.14	29.48	-292.33	-2.12K
Unlevered Free Cash Flow Margin	54.45	40.14	29.48	-292.33	-2.1K
Asset Turnover
Asset Turnover	0.24	0.09	0.05	0	0
Fixed Assets Turnover	663.06	332.88	127.45	9.92	9.78
Short Term Liquidity
Current Ratio	9.59	5.45	2	1.06	0.3
Quick Ratio	9.58	5.44	1.99	1.04	0.27
Operating Cash Flow to Current Liabilities	-3.19	-2.45	-1.28	-0.98	-0.59
Long Term Solvency
Total Debt/Equity	-	-	-	-	4.88
Total Debt / Total Capital	-	-	-	-	4.66
Total Liabilities / Total Assets	1.77	1.84	4.07	6	13.77
EBIT / Interest Expense	-	-	-	-	-128.5
EBITDA / Interest Expense	-	-	-	-	-127.92
(EBITDA - Capex) / Interest Expense	-	-	-	-	-127.92
Total Debt / EBITDA	-	-	-	-	-0.49
Net Debt / EBITDA	-1.04	-2.89	10.51	0.58	-0.26
Total Debt / (EBITDA - Capex)	-	-	-	-	-0.49
Net Debt / (EBITDA - Capex)	-1.04	-2.91	9.8	0.58	-0.26
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	42.86	-60.78	-55.59	-93.56	-63.03
Gross Profit, 1 Yr. Growth %	42.86	-60.78	-55.59	-93.56	-63.03
EBITDA, 1 Yr. Growth %	60.21	-79.47	-114.23	1.04K	-35.48
EBITA, 1 Yr. Growth %	60.25	-79.56	-115.13	980.09	-35.4
EBIT, 1 Yr. Growth %	60.25	-79.56	-115.13	980.09	-35.4
Earnings From Cont. Operations, 1 Yr. Growth %	95.85	-161.64	349.99	-57.04	45.7
Net Income, 1 Yr. Growth %	95.85	-161.64	349.99	-57.04	45.7
Normalized Net Income, 1 Yr. Growth %	60.71	-79.3	-113.91	333.17	70.5
Diluted EPS Before Extra, 1 Yr. Growth %	75	-156.52	360.89	-57.13	23.33
Net Property, Plant and Equip., 1 Yr. Growth %	-40	8.33	23.08	-50	-87.5
Total Assets, 1 Yr. Growth %	26.82	-6.09	-34.16	-17.37	-28.36
Tangible Book Value, 1 Yr. Growth %	28.63	-6.16	-35.66	-19.03	-34.28
Common Equity, 1 Yr. Growth %	28.63	-6.16	-35.66	-19.03	-34.28
Cash From Operations, 1 Yr. Growth %	17.81	-20.99	-23.75	-7.01	-0.27
Capital Expenditures, 1 Yr. Growth %	-	-	66.67	-	-
Levered Free Cash Flow, 1 Yr. Growth %	-3.98	-71.09	-67.38	-163.84	167.98
Unlevered Free Cash Flow, 1 Yr. Growth %	-3.98	-71.09	-67.38	-163.84	165.83
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	20.52	-25.14	-58.26	-83.09	-84.57
Gross Profit, 2 Yr. CAGR %	20.52	-25.14	-58.26	-83.09	-84.57
EBITDA, 2 Yr. CAGR %	21.39	-42.65	-82.91	27.26	171.01
EBITA, 2 Yr. CAGR %	21.37	-42.77	-82.42	27.82	164.15
EBIT, 2 Yr. CAGR %	21.37	-42.77	-82.42	27.82	164.15
Earnings From Cont. Operations, 2 Yr. CAGR %	13.37	9.87	66.54	39.04	-20.88
Net Income, 2 Yr. CAGR %	13.37	9.87	66.54	39.04	-20.88
Normalized Net Income, 2 Yr. CAGR %	25.06	-42.32	-83.03	-22.38	171.76
Diluted EPS Before Extra, 2 Yr. CAGR %	2.27	0.31	61.4	40.3	-27.34
Net Property, Plant and Equip., 2 Yr. CAGR %	100	-19.38	15.47	-21.55	-75
Total Assets, 2 Yr. CAGR %	25.51	9.13	-21.37	-26.24	-23.06
Tangible Book Value, 2 Yr. CAGR %	26.26	9.87	-22.3	-27.82	-27.05
Common Equity, 2 Yr. CAGR %	26.26	9.87	-22.3	-27.82	-27.05
Cash From Operations, 2 Yr. CAGR %	5.06	-3.52	-22.38	-15.79	-3.7
Capital Expenditures, 2 Yr. CAGR %	-	-37.45	-	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	30.87	-47.31	-69.29	-54.36	30.8
Unlevered Free Cash Flow, 2 Yr. CAGR %	30.34	-47.31	-69.29	-54.36	30.28
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	49.19	-17.1	-37.1	-77.62	-78.05
Gross Profit, 3 Yr. CAGR %	49.19	-17.1	-37.1	-77.62	-78.05
EBITDA, 3 Yr. CAGR %	78.22	-32.87	-63.96	-30.72	1.48
EBITA, 3 Yr. CAGR %	78.53	-32.97	-63.27	-30.62	1.81
EBIT, 3 Yr. CAGR %	78.53	-32.97	-63.27	-30.62	1.81
Earnings From Cont. Operations, 3 Yr. CAGR %	88.34	-7.47	75.79	6.02	41.23
Net Income, 3 Yr. CAGR %	88.34	-7.47	75.79	6.02	41.23
Normalized Net Income, 3 Yr. CAGR %	101.07	-31.34	-64.1	-50.04	0.9
Diluted EPS Before Extra, 3 Yr. CAGR %	70.98	-14.62	66.76	3.62	34.33
Net Property, Plant and Equip., 3 Yr. CAGR %	19.68	63.03	-7.17	-12.64	-57.47
Total Assets, 3 Yr. CAGR %	26.19	13.94	-7.79	-20.06	-26.95
Tangible Book Value, 3 Yr. CAGR %	26.74	14.37	-8.08	-21.22	-30.04
Common Equity, 3 Yr. CAGR %	26.74	14.37	-8.08	-21.22	-30.04
Cash From Operations, 3 Yr. CAGR %	15.44	-4.46	-10.8	-17.56	-10.91
Capital Expenditures, 3 Yr. CAGR %	-	-	-13.28	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	34.29	-20.89	-55.09	-60.8	-17.66
Unlevered Free Cash Flow, 3 Yr. CAGR %	34.28	-21.1	-55.09	-60.8	-17.88
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	52.58	-3.94	-10.37	-56.11	-64.15
Gross Profit, 5 Yr. CAGR %	52.58	-3.94	-10.37	-56.11	-64.15
EBITDA, 5 Yr. CAGR %	64.61	-9.44	-30.23	-13.3	-19.23
EBITA, 5 Yr. CAGR %	64.97	-9.49	-29.36	-13.23	-19.14
EBIT, 5 Yr. CAGR %	64.97	-9.49	-29.36	-13.23	-19.14
Earnings From Cont. Operations, 5 Yr. CAGR %	10.95	48.53	79.3	8.9	27.73
Net Income, 5 Yr. CAGR %	10.95	48.53	79.3	8.9	27.73
Normalized Net Income, 5 Yr. CAGR %	18.13	10.32	-25.21	-27.89	-19.33
Diluted EPS Before Extra, 5 Yr. CAGR %	0	37.22	68.82	4.14	19.52
Net Property, Plant and Equip., 5 Yr. CAGR %	0	1.61	17.98	21.67	-45.07
Total Assets, 5 Yr. CAGR %	14.17	17.61	4.44	-4.25	-14.23
Tangible Book Value, 5 Yr. CAGR %	22.2	18.38	4.21	-4.86	-16.2
Common Equity, 5 Yr. CAGR %	22.2	18.38	4.21	-4.86	-16.2
Cash From Operations, 5 Yr. CAGR %	8.86	-5.23	-1.51	-9.17	-8.02
Capital Expenditures, 5 Yr. CAGR %	-	5.15	37.97	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	-1.28	-15.99	-25.57	-36.51	-31.13
Unlevered Free Cash Flow, 5 Yr. CAGR %	-0.47	-16.37	-25.57	-36.62	-31.24